Sequoia-backed Chinese heart valve developer Venus Medtech gets funding from DCP Capital

Sequoia-backed Chinese heart valve developer Venus Medtech gets funding from DCP Capital

Open heart surgery in progress. Photo: Pixabay

Venus Medtech, a heart valve developer in China, has secured an undisclosed amount of equity investment from China-focused private equity firm DCP Capital to further boost its research and development and the internationalisation of its existing heart valve products.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter